Search clinical trials for: Human epidermal growth factor receptor 2 (HER2)
Total 111730 results
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced Breast Cancer | HER2 Amplified | Human Epidermal Growth Factor Receptor 2 (HER2)United States, Belgium, Canada, Italy, Spain, United Kingdom
-
SOLTI Breast Cancer Research GroupNovartisCompleted
-
Orum Therapeutics USA, Inc.RecruitingHER2-positive Breast Cancer | HER-2 Gene Amplification | HER2 Gene Mutation | HER-2 Protein OverexpressionUnited States
-
Tianjin Medical University Second HospitalJiangsu HengRui Medicine Co., Ltd.UnknownSolid Tumor | HER-2 Gene Amplification | HER2 Gene Mutation | HER-2 Protein OverexpressionChina
-
BayerCompletedCancers With HER2 ExpressionUnited States, United Kingdom
-
Jonsson Comprehensive Cancer CenterEli Lilly and Company; Genentech, Inc.RecruitingMetastatic Lung Non-Small Cell Carcinoma | Refractory Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v8 | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8United States
-
University of ChicagoNot yet recruitingBreast Cancer | HER2-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
SCRI Development Innovations, LLCSeagen Inc.Recruiting
-
Washington University School of MedicineMolecular Templates, Inc.WithdrawnHER2-positive Solid Tumor | HER-2 Positive Cancer
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...Active, not recruitingBrain Tumor, Recurrent | Brain Tumor, RefractoryUnited States
-
BioNTech SEDualityBio Inc.Not yet recruiting
-
Bellicum PharmaceuticalsSuspendedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | Solid Tumor, Adult | HER-2 Gene Amplification | HER-2 Protein OverexpressionUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); PfizerTerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Breast Carcinoma Metastatic in the BrainUnited States
-
Tata Memorial HospitalTerminated
-
Virginia Commonwealth UniversityEli Lilly and Company; BayerTerminatedBreast Cancer | Metastatic Breast Cancer | Recurrent Breast CancerUnited States
-
Second Military Medical UniversityUnknown
-
Breast Cancer Trials, Australia and New ZealandNot yet recruitingBreast Cancer | Breast Cancer Female
-
H. Lee Moffitt Cancer Center and Research InstituteTerminatedBreast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | HER-2 Gene Amplification | Breast Cancer Female | HER2 Positive Breast Carcinoma | HER-2 Protein OverexpressionUnited States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedRecurrent Uterine Corpus Carcinoma | Endometrial Adenocarcinoma | Stage III Uterine Corpus Cancer AJCC v7 | Stage IV Uterine Corpus Cancer AJCC v7 | ERBB2 Gene AmplificationUnited States
-
Seagen Inc.Array BioPharmaCompleted
-
Baylor College of MedicineThe Methodist Hospital Research InstituteRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Pancreatic Adenocarcinoma | Lung Cancer | Solid Tumor | Bladder Cancer | Head and Neck Squamous Cell Carcinoma | Cancer of the Salivary GlandUnited States
-
PfizerCompleted
-
AmgenActavis Inc.CompletedBreast CancerItaly, Hungary, Russian Federation, South Africa, Spain, Serbia, Belarus, Ukraine, Chile, Germany, Bulgaria, Greece, Poland, Canada, Brazil, Mexico, Romania, United Kingdom
-
Gustave Roussy, Cancer Campus, Grand ParisEuropean CommissionCompletedUntreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast CancerFrance
-
Daiichi SankyoAstraZeneca; Daiichi Sankyo Co., Ltd.Active, not recruitingBreast CancerChina, United States, Spain, Hungary, Israel, Korea, Republic of, Taiwan, Belgium, Austria, Russian Federation, Switzerland, Portugal, France, Canada, Italy, United Kingdom, Greece, Japan, Germany, Sweden
-
Qingdao Central HospitalCompletedHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastChina
-
University of WashingtonNational Cancer Institute (NCI); National Center for Complementary and Integrative...CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | HER2/Neu PositiveUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Recurrent Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Positive | Progesterone Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7 | Postmenopausal | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 and other conditionsUnited States
-
AstraZenecaRecruitingBreast CancerRussian Federation
-
Boehringer IngelheimCompletedBreast NeoplasmsHong Kong, Taiwan, United Kingdom, Russian Federation, India, Poland
-
PfizerRecruitingBreast Cancer | Solid TumorsChina, United States, Mexico, Bulgaria, Spain, Brazil, Czechia, Argentina, South Africa
-
Eisai Inc.Completed
-
Hoffmann-La RocheCompletedGastric Cancer | Gastroesophageal Junction CancerKorea, Republic of
-
Accutar Biotechnology IncTerminatedBreast CancerUnited States
-
Consorzio OncotechCompleted
-
Genentech, Inc.Completed
-
Consorzio OncotechClinical Research Technology S.r.l.UnknownMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastItaly
-
PfizerCompleted
-
Daiichi Sankyo, Inc.Bristol-Myers Squibb; AstraZenecaActive, not recruitingBreast Cancer | Urothelial CarcinomaUnited States, Spain, Italy, Belgium, France, Germany, United Kingdom
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySun Yat-sen University; Huiping Li,M.D., Ph.D.,Peking University Cancer HospitalUnknown
-
Boehringer IngelheimCompletedBreast NeoplasmsUnited States, Australia, Hong Kong, Korea, Republic of, Thailand, Tunisia, United Kingdom
-
Spanish Breast Cancer Research GroupRoche Farma, S.ACompleted
-
University of Kansas Medical CenterPfizerTerminatedHER2-positive Breast Cancer | Breast Cancer MetastaticUnited States
-
Asan Medical CenterHoffmann-La RocheCompletedMetastatic or Recurrent Gastric Adenocarcinoma | Her-2 Positive Gastric CancerKorea, Republic of
-
University of WashingtonUnited States Department of DefenseRecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Genentech, Inc.Completed
-
Palleos Healthcare GmbHRoche Pharma AG; Cankado GmbH; WSG WOMEN´S HEALTHCARE STUDY GROUPCompleted
-
Eisai Inc.Bliss Biopharmaceutical (Hangzhou) Co., LtdRecruiting
-
Daiichi Sankyo Co., Ltd.AstraZenecaCompletedNeoplasm, GastrointestinalKorea, Republic of, Japan
-
GlaxoSmithKlineCompleted